The impact of antigenic distance on Orthopoxvirus Vaccination and Mpox Infection for cross-protective immunity

Jameson Crandell,Valter Silva Monteiro,Lauren Pischel,Zhenhao Fang,Yi Zhong,Lauren Lawres,Luciana Conde,Gustavo Meira de Asis,Gabriela Maciel,Agnieszka Zaleski,Guilherme S. Lira,Luiza M. Higa,Mallery I. Breban,Chantal B. F. Vogels,Nathan D. Grubaugh,Lydia Aoun-Barakat,Alba Grifoni,Alessandro Sette,Terezinha M. Castineiras,Sidi Chen,Inci Yildirim,Andre M. Vale,Saad B. Omer,Carolina Lucas

DOI: https://doi.org/10.1101/2024.01.31.24302065

2024-02-01

Abstract:Immunological memory mediates rapid protection following infection or vaccination including heterologous exposure. However, cross-reactive memory responses in humans remain poorly characterized. We explored the longevity and specificity of cross-protective responses to orthopoxviruses through smallpox vaccination and Mpox virus (MPXV) infection. Smallpox vaccination using Vaccinia virus (VACV)-based vaccines provides a unique opportunity to study long-term cross-protective immunity without antigen re-exposure. We assessed systemic and mucosal responses in four human cohorts, including first-(Dryvax) and/or third-generation (JYNNEOS) smallpox vaccine recipients (vaccinated 1 week-80 years ago), along with Mpox-infected individuals. First-and third-generation smallpox vaccines elicited strong VACV- and MPXV-specific antibodies. VACV-neutralizing antibodies persisted for decades in first-generation vaccine recipients and were further enhanced after JYNNEOS vaccination. However, despite the high levels of anti-MPXV-specific antibodies in the plasma, cross-neutralization activity was directly correlated with the antigenic distance. Higher neutralization was observed for the cowpox virus (CWPXV) than for MPXV, which showed lower antigenic conservation with VACV. Similarly, Mpox-infected patients had lower neutralization titers for VACV than for CWPXV. Individuals who received vaccination boosters showed more robust, diverse, and prolonged cross-neutralizing responses. Long-term memory analysis revealed an increase in neutralization capacity for VACV over decades, with 80-years-old displaying the most robust humoral response, although this trend was not observed for cross-reactive antigens. Finally, T-cell reactivity to VACV and MPXV epitopes was detected decades post-vaccination, suggesting a role of long-lasting cross-reactive T-cell memory responses in vaccine efficacy. Our findings underscore the pivotal influence of antigenic distance on vaccine effectiveness with implications for cross-protective vaccine design.

Infectious Diseases (except HIV/AIDS)

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to understand the impact of different generations of smallpox vaccines (such as the first - generation Dryvax and the third - generation JYNNEOS) on the cross - protective immune response to Orthopoxvirus infections, especially the long - term protective effects of these vaccines against Mpox infections. Specifically, the research focuses on the following aspects:

1. **Long - term protective immunity**: Evaluate the persistence and specificity of immune memory obtained through smallpox vaccination decades later, especially the long - term cross - protective immunity in the absence of re - exposure to antigens.

2. **Cross - protection mechanism**: Explore how antigenic distance (i.e., the antigenic similarity between different viruses) affects vaccine effectiveness, especially its role in cross - protective immunity. In the study, the cross - protection effects against Cowpox virus (CWPXV) and Monkeypox virus (MPXV) are specifically compared.

3. **Kinetics of immune response**: Analyze the kinetic changes of systemic and mucosal immune responses after different vaccination regimens (such as primary vaccination and booster vaccination), and how these changes affect the levels of neutralizing antibodies against different Orthopoxviruses.

4. **T - cell response**: Evaluate the role of long - term memory T - cell responses in cross - protection, especially their persistence within decades after vaccination.

Through these studies, the paper aims to reveal the impact of antigenic distance on vaccine effectiveness and provide a scientific basis for the design of more effective cross - protective vaccines. This not only helps to understand the protection mechanisms of existing vaccines but may also guide future vaccine development against multiple Orthopoxviruses.